Paul V. Goode's Insider Trades & SAST Disclosures
Paul V. Goode's most recent trade in GlucoTrack Inc was a trade of 42,000 Warrants to Purchase Common Stock done . Disclosure was reported to the exchange on July 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul V. Goode.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GlucoTrack Inc | Paul V. Goode | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 01 Jul 2024 | 42,000 | 42,000 | - | - | Warrants to Purchase Common Stock | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | 14 Jun 2024 | 15,435 | 18,989 | - | 0 | Common Stock, par value $0.001 per share | ||
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 3,277 | 3,277 | - | - | Stock option (right to buy) | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Jun 2024 | 2,100 | 2,100 | - | - | Warrants to Purchase Common Stock | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 1,500 | 3,554 | - | - | Common Stock, par value $0.001 per share | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 796 | 796 | - | - | Series A Common Warrant | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | 14 Jun 2024 | 796 | 2,054 | - | 31.2 | 24,835 | Common Stock, par value $0.001 per share | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 796 | 796 | - | - | Series B Common Warrant | |
| GlucoTrack Inc | Paul V. Goode | Director, Chief Executive Officer | 14 Jun 2024 | 796 | 0 | - | - | Series B Common Warrant |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges